dc.contributor.author |
Poppitt, Sally |
en |
dc.date.accessioned |
2017-10-11T23:51:01Z |
en |
dc.date.issued |
2017-06 |
en |
dc.identifier.citation |
Current Research in Diabetes & Obesity Journal 2(3):55590 Jun 2017 |
en |
dc.identifier.issn |
2476-1435 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/35980 |
en |
dc.description.abstract |
Global numbers of overweight and obesity have been increasing steadily for the past few decades, driving a rapid parallel increase in type 2 diabetes (T2D) morbidity and associated mortality. Hindered by our inability to clearly define the characteristics and therefore the assessment biomarkers for ‘pre-diabetes’, there remains significant difficulty in identifying those most at risk, essential in order to prioritize public health initiatives for those who would most benefit from ‘fast-track’ prevention. Implementation of a population-wide approach to T2D prevention is likely to be prohibitively expensive and unsuccessful, so more focused strategies are required. ‘Pre-diabetes’ is defined by any/all of 4 biomarker methods, comprising impaired fasting glucose (IFG), impaired glucose tolerance (IGT), IFG plus IGT, and mildly raised HbA1c. Each definition defines quite different sub-cohorts of the population, hence quite different risk profile, and may lead to both ‘missed’ and ‘false positive’ pre- diabetics. This problem must be resolved before we are able to make substantial strides and reliably choose who is most at risk and would most benefit from ‘fast-track’ into diabetes lifestyle and or pharmaceutical prevention. |
en |
dc.publisher |
Juniper Publishers |
en |
dc.relation.ispartofseries |
Current Research in Diabetes & Obesity Journal |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from https://juniperpublishers.com/open-access.php |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.rights.uri |
https://creativecommons.org/licenses/by/4.0/ |
en |
dc.title |
Hyperglycaemia, pre-diabetes and diabesity: Can we choose who to ‘fast-track’ into diabetes prevention? |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.19080/CRDOJ.2017.2.555590 |
en |
pubs.issue |
3 |
en |
pubs.volume |
2 |
en |
dc.description.version |
VoR - Version of Record |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |
pubs.subtype |
Editorial Comment |
en |
pubs.elements-id |
631836 |
en |
pubs.org-id |
Science |
en |
pubs.org-id |
Biological Sciences |
en |
dc.identifier.eissn |
2476-1435 |
en |
pubs.number |
55590 |
en |
pubs.record-created-at-source-date |
2017-06-22 |
en |